Paul Edward Gross is Officer of Clovis Oncology, Inc.. Currently has a direct ownership of 98,330 shares of CLVS, which is worth approximately $8,849. The most recent transaction as insider was on May 01, 2021, when has been sold 10,248 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 98.3K
0% 3M change
0% 12M change
Total Value Held $8,849

Paul Edward Gross Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 01 2021
BUY
Exercise of conversion of derivative security
-
10,248 Added 16.9%
50,379 Common Stock
Mar 02 2021
SELL
Open market or private sale
$2,868 $6.29 p/Share
456 Reduced 1.04%
43,521 Common Stock
Mar 01 2021
BUY
Exercise of conversion of derivative security
-
1,032 Added 2.3%
43,770 Common Stock
Feb 02 2021
SELL
Open market or private sale
$94,628 $7.97 p/Share
11,873 Reduced 21.66%
42,945 Common Stock
Feb 01 2021
BUY
Exercise of conversion of derivative security
-
24,125 Added 31.61%
52,200 Common Stock
Dec 03 2020
SELL
Open market or private sale
$2,235 $4.89 p/Share
457 Reduced 1.47%
30,693 Common Stock
Dec 03 2020
BUY
Exercise of conversion of derivative security
-
1,031 Added 3.22%
30,942 Common Stock
Nov 03 2020
SELL
Open market or private sale
$5,679 $4.93 p/Share
1,152 Reduced 3.89%
28,434 Common Stock
Nov 03 2020
BUY
Exercise of conversion of derivative security
-
5,623 Added 15.15%
31,501 Common Stock
Aug 03 2020
SELL
Open market or private sale
$6,813 $4.93 p/Share
1,382 Reduced 4.39%
30,119 Common Stock
PEG

Paul Edward Gross

Officer
Boulder, CO

Track Institutional and Insider Activities on CLVS

Follow Clovis Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLVS shares.

Notify only if

Insider Trading

Get notified when an Clovis Oncology, Inc. insider buys or sells CLVS shares.

Notify only if

News

Receive news related to Clovis Oncology, Inc.

Track Activities on CLVS